Deal announced
Exhibit 99.4  Arix Bioscience plc Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Merger to create a Nasdaq-listed, clinical stage biopharmaceutical company focused on advancing Disc Medicine's portfolio of haematology programmes
This is the opening of the release as filed. Read the full document on SEC.gov, or read it in full on SPAC Watch with the trust, deadline and warrant terms alongside it.
Every SPAC announcement, read and classified.
Announcements are pulled from 8-K exhibits as they are filed, classified by what they announce, and attached to the SPAC they belong to.
No card requiredSourced directly from EDGAR